Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer

• Główni autorzy: Yihang Qi (Autor), Wenxiang Zhang (Autor), Ray Jiang (Autor), Olivia Xu (Autor), Xiangyi Kong (Autor), Lin Zhang (Autor), Yi Fang (Autor), Jingping Wang (Autor), Jing Wang (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy (CT) is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple-negative breast cancer (TNBC). However, several published randomized controlled trials (RCTs) reported heterogene...